Literature DB >> 1971446

Antagonism of behavioral effects of cocaine by selective dopamine receptor blockers.

R D Spealman1.   

Abstract

The cocaine-antagonist effects of SCH 39166, which selectively blocks D1 dopamine receptors, were compared with those of YM 09151-2, a selective D2 receptor blocker, and flupenthixol, a nonselective blocker of both dopamine receptor subtypes. Squirrel monkeys were studied under a fixed-interval schedule of stimulus-shock termination, and the effects of cumulative doses of cocaine were determined alone and after pretreatment with each dopamine receptor blocker. When administered alone, cocaine (0.01-1.78 mg/kg, IV) had biphasic effects on responding: intermediate doses increased response rate, whereas higher doses decreased response rate. The ED50 for cocaine (average does that produced a half-maximal increase in response rate) was 0.04 mg/kg. Pretreatment with SCH 39166 (0.03 and 0.1 mg/kg, IV) resulted in surmountable antagonism of both the rate-increasing and rate-decreasing effects of cocaine, the ED50 being increased by as much as 13-fold. Similar effects were observed after pretreatment with YM 09151-2 (0.001 and 0.003 mg/kg, IV) and flupenthixol (0.01 and 0.03 mg/kg, IV), which respectively produced up to a 13-fold and 32-fold increase in ED50. There also was evidence for reciprocal antagonism of the rate-decreasing effects of the three dopamine receptor blockers by cocaine. The results suggest a prominent role for D1 as well as D2 dopamine receptors in mediating the effects of cocaine on schedule-controlled behavior.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1971446     DOI: 10.1007/bf02253732

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  15 in total

1.  Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.

Authors:  R E Chipkin; L C Iorio; V L Coffin; R D McQuade; J G Berger; A Barnett
Journal:  J Pharmacol Exp Ther       Date:  1988-12       Impact factor: 4.030

2.  The comparative pharmacology of flupenthixol and some reference neuroleptics.

Authors:  I M Nielsen; V Pedersen; M Nymark; K F Franck; V Boeck; B Fjalland; A V Christensen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1973

3.  Estimation of relative antiavoidance activity of depressant drugs in squirrel monkeys.

Authors:  H M Hanson; J J Witoslawski; E H Campbell; A G Itkin
Journal:  Arch Int Pharmacodyn Ther       Date:  1966-05

4.  Arterial hypertension in the squirrel monkey during behavioral experiments.

Authors:  J A Herd; W H Morse; R T Kelleher; L G Jones
Journal:  Am J Physiol       Date:  1969-07

5.  Behavioral effects of histamine H1 antagonists: comparison with other drugs and modification by haloperidol.

Authors:  J Bergman; R D Spealman
Journal:  J Pharmacol Exp Ther       Date:  1988-05       Impact factor: 4.030

6.  Chlorpromazine effects on cocaine-reinforced responding in rhesus monkeys: reciprocal modification of rate-altering effects of the drugs.

Authors:  S Herling; J H Woods
Journal:  J Pharmacol Exp Ther       Date:  1980-08       Impact factor: 4.030

7.  Pharmacological studies on a new benzamide derivative, YM-09151-2, with potential neuroleptic properties.

Authors:  M Yamamoto; S Usuda; S Tachikawa; H Maeno
Journal:  Neuropharmacology       Date:  1982-10       Impact factor: 5.250

8.  Some effects of cocaine and two cocaine analogs on schedule-controlled behavior of squirrel monkeys.

Authors:  R D Spealman; S R Goldberg; R T Kelleher; D M Goldberg; J P Charlton
Journal:  J Pharmacol Exp Ther       Date:  1977-09       Impact factor: 4.030

9.  The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat.

Authors:  G F Koob; H T Le; I Creese
Journal:  Neurosci Lett       Date:  1987-08-31       Impact factor: 3.046

10.  Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior.

Authors:  R D Spealman; B K Madras; J Bergman
Journal:  J Pharmacol Exp Ther       Date:  1989-10       Impact factor: 4.030

View more
  6 in total

Review 1.  The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence.

Authors:  Christian A Heidbreder; Eliot L Gardner; Zheng-Xiong Xi; Panayotis K Thanos; Manolo Mugnaini; Jim J Hagan; Charles R Ashby
Journal:  Brain Res Brain Res Rev       Date:  2005-07

2.  Observational studies of dopamine D1 and D2 agonists in squirrel monkeys.

Authors:  S Rosenzweig-Lipson; P Hesterberg; J Bergman
Journal:  Psychopharmacology (Berl)       Date:  1994-09       Impact factor: 4.530

3.  Interaction of haloperidol and SCH 23390 with cocaine and dopamine receptor subtype-selective agonists on schedule-controlled behavior of squirrel monkeys.

Authors:  J M Witkin; C W Schindler; S R Tella; S R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Strain-dependent effects of post-training cocaine or nomifensine on memory storage involve both D1 and D2 dopamine receptors.

Authors:  S Puglisi-Allegra; V Cestari; S Cabib; C Castellano
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

5.  Inhibitory Effects of Coptidis rhizoma and Berberine on Cocaine-induced Sensitization.

Authors:  Bombi Lee; Chae Ha Yang; Dae-Hyun Hahm; Eun Sang Choe; Hye-Jung Lee; Kwang-Ho Pyun; Insop Shim
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-18       Impact factor: 2.629

6.  Personality Traits or Genetic Determinants-Which Strongly Influences E-Cigarette Users?

Authors:  Anna Grzywacz; Aleksandra Suchanecka; Jolanta Chmielowiec; Krzysztof Chmielowiec; Kamila Szumilas; Jolanta Masiak; Łukasz Balwicki; Monika Michałowska-Sawczyn; Grzegorz Trybek
Journal:  Int J Environ Res Public Health       Date:  2020-01-05       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.